![](https://eupati.eu/wp-content/uploads/2020/05/eupati-paradigm-logo.png)
The collaboration between EUPATI and IMI-PARADIGM:
![](https://eupati.eu/wp-content/uploads/2020/05/eupati-peof-logo-2020-468x300.jpg)
This event is co-organised by EUPATI, IMI-PARADIGM and Patient Focused Medicines Development (PFMD) and it aims to provide a holistic perspective on patient engagement, the landscape and actors, and foster collaboration and co-creation while breaking down fragmentation and silos that are often present in patient engagement work.
![](https://eupati.eu/wp-content/uploads/2020/05/eupati-patient-engagement-toolbox-1-468x311.jpg)
PARADIGM will deliver a set of tools to enable stakeholders to do patient engagement in a meaningful and systematic way. The tools will be searchable via the EUPATI Toolbox.
![](https://eupati.eu/wp-content/uploads/2020/05/EUPATI_Guidance_PatientInvolvement_Industry-468x651.jpg)
EUPATI Guidance on Patient Involvement in Medicines Research & Development
Under the IMI-PARADIGM project, the EUPATI guidance on patient involvement for pharmaceutical industry-led medicines R&D has been revised and 2 addendums added to the guidance. It can be found here.